Has Sara Banit received payments from drug or device companies?

Yes. Drug and device makers reported $1,612 in general payments to Sara Banit across 80 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sara Banit did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sara Banit come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sara Banit

Psychiatric/Mental Health · High Point, NCNPI 1649036369

Payments from drug & device makers

$1,612in general payments, 2019–2025

Across 80 payments — averaging $20.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Vanda Pharmaceuticals Inc.$237
Corium, LLC$151
Johnson & Johnson$146
Supernus Pharmaceuticals, Inc.$127
E.r. Squibb & Sons, L.L.C.$125
Alkermes, Inc.$93
plus $732 from 15 others

What the payments were for

Food & beverage$1,612100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Vanda Pharmaceuticals Inc.	8	$237
Corium, LLC	9	$151
Johnson & Johnson	6	$146
Supernus Pharmaceuticals, Inc.	7	$127
E.r. Squibb & Sons, L.L.C.	5	$125
Alkermes, Inc.	5	$93
Ironshore Pharmaceuticals Inc.	4	$85
Takeda Pharmaceuticals U.S.A., Inc.	5	$80
Otsuka America Pharmaceutical, Inc.	4	$79
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	4	$77
Neos Therapeutics, LP	4	$71
AbbVie	4	$70
Neurocrine Biosciences, Inc.	2	$50
Idorsia Pharmaceuticals US Inc	2	$37
Collegium Pharmaceutical, Inc.	2	$36
Tris Pharma Inc	2	$36
Teva Pharmaceuticals USA, Inc.	2	$32
Almatica Pharma LLC	2	$28
Indivior Inc.	1	$23
Noven Therapeutics, LLC	1	$15
Vertical Pharmaceuticals, LLC	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Fanapt$125

How this compares

$1,612 in reported general payments places this provider in the 70th percentile of 947 psychiatric/mental health providers in North Carolina.

See all psychiatric/mental health providers in North Carolina →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Olanzapine	17	$206
Aripiprazole	14	$195
Quetiapine Fumarate	19	$147
Trazodone Hcl	23	$136
Hydroxyzine Hcl	16	$113
Clonidine Hcl	12	$36

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in High Point

Crystal MontagueHigh Point$9K
Desiree MatthewsCharlotte$807K
Benedetto PalomboCharlotte$671K
Clarence RunnelsCreedmoor$339K
Lisa SuddrethGastonia$111K
April NandigamGreensboro$88K
Hannah NealeyFuquay Varina$75K
Jessica StoneRocky Mount$63K
Deborah GranickRaleigh$28K
Ronald PattersonFayetteville$25K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →